According to official inquiries, in the financial report of the third quarter in September 2022, Tasly's main turnover ranked 10, and Guizhou Bailing ranked 29th.
Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. is a listed pharmaceutical company engaged in research, development, production and sales of Miao medicine, with a registered capital of14.10/200 million yuan, total assets of 4.23 billion yuan and more than 5,000 employees.